Literature DB >> 12914404

[Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis].

K P Mellwig1, H K Schmidt, A Brettschneider-Meyer, H Meyer, B R Jaeger, A K Walli, D Seidel, D Horstkotte.   

Abstract

In children with familial hypercholesterolemia, coronary heart disease requires both medical theraphy and LDL apheresis. We report a case of verified occlusion of the anterior descending branch of the left coronary artery in a 10-year-old patient. The pathological findings revealed by ergometry established the diagnosis. The goal was to achieve the greatest possible reduction of lipid parameters and fibrinogen by lowering plasma viscosity employing LDL apheresis. It is astonishing that this treatment is also well tolerated by children. The basic vascular approaches suffice and shunt operations are not absolutely necessary. The efficacy of this method became vividly apparent by the changes in the skin lesions. Additional angiographic follow-up and further clinical course wil provide information on the usefulness of this treatment strategy with maximum lipid theraphy and the expected improvement in prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914404     DOI: 10.1007/s00108-002-0832-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

1.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

2.  A simple specific method for precipitation of low density lipoproteins.

Authors:  H Wieland; D Seidel
Journal:  J Lipid Res       Date:  1983-07       Impact factor: 5.922

3.  Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells.

Authors:  H J Gröne; A K Walli; E Gröne; A Krämer; M R Clemens; D Seidel
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

4.  LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.

Authors:  C Stefanutti; A Notarbartolo; V Colloridi; A Nigri; A Vivenzio; S Bertolini; G Bosco; A Berni; S Di Giacomo; B Mazzarella
Journal:  Artif Organs       Date:  1997-10       Impact factor: 3.094

5.  Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.

Authors:  R J Zwiener; R Uauy; M L Petruska; B A Huet
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

6.  Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis.

Authors:  C Stefanutti; A Vivenzio; C Colombo; S Di Giacomo; B Mazzarella; A Berni; A Nigri; N Koga
Journal:  Int J Artif Organs       Date:  1995-02       Impact factor: 1.595

7.  The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.

Authors:  P Schuff-Werner; H Gohlke; U Bartmann; G Baggio; M C Corti; A Dinsenbacher; T Eisenhauer; P Grützmacher; C Keller; U Kettner
Journal:  Eur J Clin Invest       Date:  1994-11       Impact factor: 4.686

8.  Improvement of coronary vasodilatation capacity through single LDL apheresis.

Authors:  K P Mellwig; D Baller; U Gleichmann; D Moll; S Betker; R Weise; G Notohamiprodjo
Journal:  Atherosclerosis       Date:  1998-07       Impact factor: 5.162

9.  Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).

Authors:  P Schuff-Werner; E Schütz; W C Seyde; T Eisenhauer; G Janning; V W Armstrong; D Seidel
Journal:  Eur J Clin Invest       Date:  1989-02       Impact factor: 4.686

10.  Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients.

Authors:  D L Sprecher; E J Schaefer; K M Kent; R E Gregg; L A Zech; J M Hoeg; B McManus; W C Roberts; H B Brewer
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.